GenoFocus (187420) Stock Overview

GenoFocus, Inc. develops and sells enzyme solutions for specialty food, eco-friendly process, biopharmaceutical, cosmeceutical, and agriculture applications in South Korea. Its products for specialty food products include lactase, chitosanase, and gamma-aminobutyric acid, as well as vitamin K2 and nattokinase; and eco-solutions comprise catalase for use in semiconductor and textile processes, as well as cellulase for use in textile processes. The company also offers products for cosmeceuticals, such as bio retinol, mutanase, enzymes for compound-k production, and superoxide dismutase; products for pharmaceuticals, including lipase for use in API synthesis and proteinase K for molecular diagnostics; bio defense products comprising biological and chemical agents; and agriculture products consisting of aminolevulinic acid and phytase enzymes. In addition, it develops enzymes for alleviating health problems associated with digestion, gastrointestinal disease, inflammation, autoimmune disease, and aging. GenoFocus, Inc. was incorporated in 2000 and is based in Daejeon, South Korea.